Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

NCT00706862 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Talactoferrin
DRUG: Placebo

Sponsor

Agennix